(ISSN 2573-4407)
OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 7.5 weeks; Submission to Acceptance: 15.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)
Special Issue
Novel Concepts of Mood and Anxiety in Children
Submission Deadline: March 15, 2021 (Open) Submit Now
Guest Editor
Bettina Bernstein
Clinical Associate Professor of Psychiatry, Department of Psychiatry and Psychiatric Medicine, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA
Research Interests: Complementary and Integrative Medicine, Population Health Interventions to Prevent Anxiety and Mood Disorders in Youth, Prevention of Burnout of Medical Students
About This Topic
Why new effective approaches to the treatment and prevention of mood and anxiety disorders matter. Prevention and amelioration of youth incidence of mood and anxiety disorders is especially salient due to concerns that at this time all persons may be at higher risk due to anxiety generated by the current COVID 19 pandemic.
Data from the National Comorbidity Adolescent Supplement (NCS‐A) study in 2009, have found that as many one-third of all adolescents in the United States (US) have any type of anxiety disorder with approximately one-tenth of the those with anxiety disorders experiencing severe impairment which can interfere with the typical developmental path to adulthood. In 2009, overall 14 percent of adolescents in the US age 12 to 17 years had any type of mood disorder. As of 2017, 3.2 million of adolescents in the US representing 13.3 percent of the today had major depression. Interventions that can reduce mood disorders including major depression may help to reduce suicide which according to CDC data in 2017 is the second leading cause of death among youth in the United States. Complementary and integrative approaches added to or used instead of conventional psychotherapies and psychiatric medications are needed to more broadly disseminate effective strategies for persons who experience problematic side effects or lack of response.
Submissions to cover areas such as complementary and integrative approaches including mindfulness and relaxation-based practices are especially welcome; these practices are generally considered safe for healthy people, however evidence based data on the safety of these practices is needed for persons with a history of abuse or trauma as well as epilepsy or other psychiatric conditions that include psychosis; modifications of practices to improve safety would be extremely helpful for successful clinical usage. Articles should include safety, efficacy and cost effectiveness-data utilizing scientifically sound statistical analyses.
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (neurobiology@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
Publication
Innovative Strategies and Challenges for the Prevention of Pathological Anxiety in Children and AdolescentsAbstract The effects of pathological anxiety on public health have led to the realization that anxious children might experience significant limitations in their lives. Evidence-based cognitive-behavioral (CB) interventions are now being implemented in schools at a group level to combat anxiety.Childhood emotional health should be considere [...] |
TOP
Vidhi is a Clinical yoga therapist; mentor for yoga therapy training in Krishnamacharya tradition. She holds a MSc in Public health from Kings College London.
Mirela Olympia Fagarasan Palmer
Luigi Fontana, MD, PhD.jpg)
Zhong-Ting (Justin) is a PhD student from Nanyang Technological University (Singapore). He holds BSc in Applied Chemistry and MSc in Environmental Engineering. He was a R&D researcher of NanoMaterials Technology Pte Ltd in Singapore (2006-2012). His current research interests are functional nanomaterials synthesis & design, and their application into environmental/chemical engineering. He has published near 60 SCI papers in Applied Catalysis B, Chemical Engineering Journal and so on with H-Index 23. He also serviced as reviewers over 40 Journals such as Appl. Catal. B, Water Research, Chem. Eng. J, ACS Applied Materials & Interface, etc. He was honored such as “The Bsic Research Achievment 1st Award of CIESC”, “The ZJUT Fund Breeding Distinguished Young Scholars” etc.
Rolf Teschke studied Medicine in Munich and Marburg, where he finished his MD thesis before starting a residency at the Department of Pathology, University of Marburg. Subsequently and with a fellowship of the Deutsche Forschungsgmeinschaft, he worked at the Bronx VA Hospital/Mount Sinai Hospital in New York during 1972–1975 together with Professor Charles S. Lieber and successfully isolated MEOS and expanded its characterization. Back in Germany, he was at the Heinrich-Heine University in Düsseldorf with a focus on alcoholic liver disease, biochemical drug studies, and clinical intoxications by halogenated aliphatic hydrocarbons, where he became a Professor of Medicine. In 1987, he was offered a chief position and appointed as Director of the Medical Department II, City Hospital Hanau, Teaching Hospital of the Johann Wolfgang Goethe University Frankfurt/Main. His clinical and research interests are on liver injury by drugs and herbs including causality assessment by RUCAM in close association with Dr. Gaby Danan in Paris. A perfect cooperation exists also with Professor Tran Dang Xuan of the University of Hiroshima, Japan. Finally, he is the author of more than 275 publications including books and book chapters, and he is editor in chief of scientific journals and member of editorial boards.